A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
4hon MSN
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
1h
News Medical on MSNCan coffee push back Parkinson’s? New study uncovers key genetic linkHigher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or ...
The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product ...
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...
A new study reveals that working memory limitations stem from learning challenges rather than storage capacity.
The capacity of one's working memory -- how many tasks can be performed simultaneously -- is considered to be limited.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results